Loading...

The End Point Is Just the Beginning

Clinical trials to support registration of new drugs are arduous, lengthy, and expensive. Diabetes treatment trials intended to seek indications for glycemic control are facilitated by the regulatory acceptance of glycosylated hemoglobin (A1C) as a validated intermediate efficacy end point. However,...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Hovedforfatter: Muchmore, Douglas
Format: Artigo
Sprog:Inglês
Udgivet: Diabetes Technology Society 2011
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3208893/
https://ncbi.nlm.nih.gov/pubmed/22027330
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!